02181 MABPHARM-B
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.17X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 220.2% | Net Margin | N/A |
Total Debt/Equity | 329.6% | Return on Equity | N/A |
Price/Book | 34.06X | Return on Assets | N/A |
(HKD 0.780) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -136.07 | -230.75 | -236.37 | -356.83 | -219.12 |
---|---|---|---|---|---|
Net Profit Growth (%) | +41.0 | +2.4 | +33.8 | -62.9 | +3.2 |
Earnings Per Share (HKD) | -0.033 | -0.056 | -0.057 | -0.087 | -0.053 |
Earnings Per Share Growth (%) | +41.1 | +2.3 | +33.8 | -62.9 | +10.8 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 0.023 | 0.055 | 0.109 | 0.179 | 0.254 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 274.183 | 108.483 | +152.7 | 44.02 |
Operating Result | 2.898 | -97.569 | -103.0 | -99.999 |
Profit Before Taxation | 2.898 | -97.569 | -103.0 | -99.999 |
Profit /( Loss) After Taxation | 2.898 | -97.569 | -103.0 | -99.999 |
Net Profit | 2.898 | -97.569 | -103.0 | -99.999 |
Earnings Per Share () | 0.0008 | -0.0254 | -103.1 | -0.0262 |
Announcement Date | 2025-08-28 | 2024-08-28 | NA | 2023-08-25 |
* Annualised
Last Update Time: 2025-09-08 21:40:25